Abstract
Purpose
To review the demographic and clinical features and the success rates of treatment approaches for idiopathic granulomatous mastitis (IGM).
Methods
A total of 134 patients diagnosed with IGM pathologically and treated by a single breast surgeon were retrospectively analyzed.
Results
The time between the occurrence of symptoms and the last delivery was < 24 months in 25 (23.1%), 24–48 months in 51 (38.1%), and > 48 months in 52 (38.8%). The difference was statistically significant (p = 0.002). Although there was no significant difference, seasonal fluctuations were noticed, with the incidence being slightly higher during late spring and summer. Bilateral disease was present in 10 (7.5%) patients. Seven patients (5.2%) had erythema nodosum. The treatment approaches were conservative in 42, surgical procedures in 48, steroid treatment in 18, and surgical procedure + steroid treatment in 24. The median recovery time with conservative approaches was lower than that with surgical procedure + steroid treatment (p < 0.0001). Recurrence developed in 10 patients (7.7%).
Conclusion
Clinical differences were detected among the patients with IGM, and classification of patients by severity is needed to plan the optimal treatment approach. Seasonal fluctuations suggest the possibility of an immunological disease rather than a surgical disease.
Similar content being viewed by others
References
Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol. 1972;58:642–6.
Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases. 2014;2:852–8.
Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol. 2016;12:1381–94.
Koksal H. Human leukocyte antigens class I and II in patients with idiopathic granulomatous mastitis. Am J Surg. 2019;218:605–8.
Akın M, Karabacak H, Esendağlı G, Yavuz A, Gultekin S, Dikme K, et al. Coexistence of idiopathic granulomatous mastitis and erythemanodosum: successful treatment with corticosteroids. Turk J Med Sci. 2017;47:1590–2.
Salesi M, Karimifar M, Salimi F, Mahzouni P. A case of granulomatous mastitis with erythema nodosum and arthritis. Rheumatol Int. 2011;31:1093–5.
Binesh F, Shiryazdi M, Bagher Owlia M, Azimi S. Idiopathic granulomatous mastitis, erythema nodosum and bilateral ankle arthritis in an Iranian woman. BMJ Case Rep. 2013; 2013: bcr2012007636.
Zabetian S, Friedman BJ, McHargue C. A case of idiopathic granulomatous mastitis associated with erythema nodosum, arthritis, and reactive cough. JAAD Case Rep. 2016;2:125–7.
Alungal J, Abdulla MC, Narayan R. Idiopathic granulomatous mastitis with erythema nodosum and polyarthritis. Reumatismo. 2016;68:97–9.
Vural S, Ertop P, Ceyhan K, Şanli H. An unusual cause of oligoarthritis and erythema nodosum: idiopathic granulomatous mastitis. Arch Rheumatol. 2017;32:71–5.
Letourneux C, Diemunsch P, Korganow AS, Akladios CY, Bellocq JP, Mathelin C. First report of granulomatous mastitis associated with Sjögren’s syndrome. World J Surg Oncol. 2013;11:268.
Velidedeoglu M, Kilic F, Mete B, Yemisen M, Celik V, Gazioglu E, et al. Bilateral idiopathic granulomatous mastitis. Asian J Surg. 2016;39:12–20.
Koksal H, Vatansev H, Artac H, Kadoglou N. The clinical value of interleukins-8, -10, and -17 in idiopathic granulomatous mastitis. Clin Rheumatol. 2020;39:1671–7.
Saydam M, Yilmaz KB, Sahin M, Yanik H, Akinci M, Yilmaz I, et al. New findings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels of patients. J Invest Surg. 2020. https://doi.org/10.1080/08941939.2020.1725190 ((published online ahead of print, 2020 Feb 11)).
Cohen C. Granulomatous mastitis: areview of 5 cases. S Afr Med J. 1977;52:14–6.
Yaghan R, Hamouri S, Ayoub NM, Yaghan L, Mazahreh T. A proposal of a clinically based classification for idiopathic granulomatous mastitis. Asian Pac J Cancer Prev. 2019;20:929–34.
Altintoprak F, Karakece E, Kivilcim T, Dikicier E, Cakmak G, Celebi F, et al. Idiopathic granulomatous mastitis: an autoimmune disease? Sci World J. 2013;2013:148727.
Sheybani F, Naderi HR, Gharib M, Sarvghad M, Mirfeizi Z. Idiopathic granulomatous mastitis: long-discussed but yet-to-be-known. Autoimmunity. 2016;49:236–9.
Ozel L, Unal A, Unal E, Kara M, Erdoğdu E, Krand O, et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surg Today. 2012;42:729–33.
Çetin K, Sıkar HE, Göret NE, Rona G, Barisik NO, Kucuk HF, et al. Comparison of topical, systemic, and combined therapy with steroids on idiopathic granulomatous mastitis: a prospective randomized study. World J Surg. 2019;43:2865–73.
Gulluoglu BM. Idiopathic granulomatous mastitis: do we really regard it as a surgical disease anymore? World J Surg. 2015;39:2724–5.
Martinez-Ramos D, Simon-Monterde L, Suelves-Piqueres C, Queralt-Martin R, Granel-Villach L, Laguna-Sastre JM, et al. Idiopathic granulomatous mastitis: a systematic review of 3060 patients. Breast J. 2019;25:1245–50.
Uysal E, Soran A, Sezgin E, Granulomatous Mastitis Study Group. Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study? ANZ J Surg. 2018;88:635–9.
Azizi A, Prasath V, Canner J, Gharib M, Sadat Fattahi A, Naser Forghani M, et al. Idiopathic granulomatous mastitis: management and predictors of recurrence in 474 patients. Breast J. 2020. https://doi.org/10.1111/tbj.13822 (published online ahead of print, 2020 Apr 5).
Cohn J. Thrombocytopenia in childhood: an evaluation of 433 patients. Scand J Haematol. 1976;16:226–40.
Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR, Intercontinental childhood ITP study group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001;358:2122–5.
Moulis G, Guénin S, Limal N, Michel M, Bierling P, Godeau B, et al. Seasonal variations of incident primary immune thrombocytopenia in adults: an ecological study. Eur J Intern Med. 2017;37:e26–8. https://doi.org/10.1016/j.ejim.2016.09.025.
Çiftci F, Abdurrahman İ, Tatar Z. The effect of corticosteroid treatment on bilateral idiopathic granulomatous mastitis. Turk J Surg. 2015;33:113–5.
Irkorucu O. Granulomatous mastitis: we need a useful classification system. Am J Surg. 2018;216:642.
Bouton ME, Jayaram L, O’Neill PJ, Hsu CH, Komenaka IK. Management of idiopathic granulomatous mastitis with observation. Am J Surg. 2015;210:258–62.
Yuksekdag S, Yildiz A, Yildirak K, Ayranci G, Cibiroglu E, Ezberci F, et al. Conservative management of 154 patients with idiopathic granulomatous mastitis: simple is better? Ann Ital Chir. 2020;91:154–60.
Kıvılcım T, Altıntoprak F, Memiş B, Ferhatoğlu MF, Kartal A, Dikicier E, et al. Role of bacteriological agents in idiopathic granulomatous mastitis: real or not? Eur J Breast Health. 2018;15:32–6.
Gunduz Y, Altintoprak F, Tatli Ayhan L, Kivilcim T, Celebi F. Effect of topical steroid treatment on idiopathic granulomatous mastitis: clinical and radiologic evaluation. Breast J. 2014;20:586–91.
Montazer M, Dadashzadeh M, Moosavi Toomatari SE. Comparison of the outcome of low dose and high-dose corticosteroid in the treatment of idiopathic granulomatous mastitis. Asian Pac J Cancer Prev. 2020;21:993–6.
Cetin K, Sıkar HE, Goret NE, Rona G, Barisik NO, Kuçuk HF, et al. Comparison of topical, systemic, and combined therapy with steroids on idiopathic granulomatous mastitis: a prospective randomized study. World J Surg. 2019;43:2865–73.
Toktas O, Konca C, Trabulus DC, Soyder A, Koksal H, Karanlik H, et al. A novel first-line treatment alternative for noncomplicated idiopathic granulomatous mastitis: combined intralesional steroid injection with topical steroid administration. Breast Care. 2020. https://doi.org/10.1159/000507951.
Co M, Cheng VCC, Wei J, Wong SCY, Chan SMS, Shek T, et al. Idiopathic granulomatous mastitis: a 10-year study from a multicentre clinical database. Pathology. 2018;50:742–7.
Acknowledgements
We would like to thank the pathology and radiology departments for their contributions to the diagnosis of the patients included in the study.
Funding
The authors declare that this study has received no financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest was declared by the author.
Ethics committee approval
Ethics committee approval was received for this study from the ethics committee of Selcuk University (No: 2020/265).
Informed consent
Written informed consent was not obtained due to the retrospective nature of the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Koksal, H. What are the new findings with regard to the mysterious disease idiopathic granulomatous mastitis?. Surg Today 51, 1158–1168 (2021). https://doi.org/10.1007/s00595-020-02204-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-020-02204-2